![Christopher Galletta](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 368 983 $ as of 2026-05-30
Christopher Galletta is currently Chief Accounting Officer & Controller at Trevi Therapeutics, Inc., a position held since 2021.
Formerly, Mr. Galletta was Director-Financial Reporting at SS&C Technologies Holdings, Inc. from 2016 to 2021, Chief Accounting Officer & Controller at TransAct Technologies, Inc. in 2011, and Assistant Vice President-Accounting at Virtus Investment Partners, Inc. from 2011 to 2016.
Mr. Galletta completed undergraduate studies at Frank G.
Zarb School of Business in 2000.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-18 | 26,095 ( 0.02% ) | 368 983 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 2021-04-11 |
| Companies | Position | End |
|---|---|---|
| SS&C TECHNOLOGIES HOLDINGS, INC. | Corporate Officer/Principal | 2021-02-28 |
| VIRTUS INVESTMENT PARTNERS, INC. | Corporate Officer/Principal | 2016-06-30 |
| TRANSACT TECHNOLOGIES INCORPORATED | Comptroller/Controller/Auditor | 2011-10-06 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
TransAct Technologies, Inc.
 TransAct Technologies, Inc. Computer PeripheralsElectronic Technology Develops and sells software-driven technology and printers | Electronic Technology |
SS&C Technologies Holdings, Inc.
 SS&C Technologies Holdings, Inc. Packaged SoftwareTechnology Services Provides software-enabled services to the alternative investment managers, financial and healthcare industries | Technology Services |
Virtus Investment Partners, Inc.
 Virtus Investment Partners, Inc. Investment ManagersFinance Provides investment management services | Finance |
Trevi Therapeutics, Inc.
 Trevi Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment for cough conditions | Health Technology |
Frank G. Zarb School of Business
 Frank G. Zarb School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions
